Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Malignant bone tumors.

Literature DB >> 12064130

Malignant bone tumors.

C Parker Gibbs¹, Kristy Weber, Mark T Scarborough.

Abstract

Entities: Disease

Mesh：

Substances：
Antineoplastic Agents

Year: 2002 PMID： 12064130

Source DB: PubMed Journal: Instr Course Lect ISSN： 0065-6895

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

1. Evidence for the osteosarcoma stem cell.

Authors: C Parker Gibbs; Padraic P Levings; Steven C Ghivizzani
Journal: Curr Orthop Pract Date: 2011-07

2. Identification of Differentially Expressed Genes under the Regulation of Transcription Factors in Osteosarcoma.

Authors: Yang Liu; Jianzhong Guan; Xiaotian Chen
Journal: Pathol Oncol Res Date: 2018-11-08 Impact factor: 3.201

3. Stem-like cells in bone sarcomas: implications for tumorigenesis.

Authors: C Parker Gibbs; Valery G Kukekov; John D Reith; Olga Tchigrinova; Oleg N Suslov; Edward W Scott; Steven C Ghivizzani; Tatyana N Ignatova; Dennis A Steindler
Journal: Neoplasia Date: 2005-11 Impact factor: 5.715

4. Reversine induces caspase-dependent apoptosis of human osteosarcoma cells through extrinsic and intrinsic apoptotic signaling pathways.

Authors: Jae-Sung Kim; In-A Cho; Kyeong-Rok Kang; HyangI Lim; Tae-Hyeon Kim; Sun-Kyoung Yu; Heung-Joong Kim; Seul Ah Lee; Sung Min Moon; Hong Sung Chun; Chun Sung Kim; Do Kyung Kim
Journal: Genes Genomics Date: 2019-04-05 Impact factor: 1.839

Malignant bone tumors.

1. Evidence for the osteosarcoma stem cell.

2. Identification of Differentially Expressed Genes under the Regulation of Transcription Factors in Osteosarcoma.

3. Stem-like cells in bone sarcomas: implications for tumorigenesis.

4. Reversine induces caspase-dependent apoptosis of human osteosarcoma cells through extrinsic and intrinsic apoptotic signaling pathways.

5. Treatment of Bone Tumors.

6. Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma.

7. Osseous tumours of the hand: a review of 99 cases in 20 years.

8. Smoothened as a new therapeutic target for human osteosarcoma.

9. Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation.

10. Enhancer of zeste homolog 2 silencing inhibits tumor growth and lung metastasis in osteosarcoma.